跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AD-107
首页
药物
AD-107
AD-107
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of miRNA in preparation of medicine for treating AD, medicine composition and application of medicine composition
申请人: SHANGHAI MENTAL HEALTH CENTER SHANGHAI PSYCHOLOGICAL COUNSELING TRAINING CENTER
优先权: 2022
CN
METHODS OF DETECTION AND ANALYSIS OF NUCLEIC ACID IN CIRCULATING BODILY FLUIDS TO DIAGNOSE COGNITIVE DISORDERS
申请人: BRAIN CHEMISTRY LABS
优先权: 2025
WO
Traditional Chinese medicinal composition for treating Alzheimer-type disease and preparation method thereof
申请人: SHANGHAI GERIATRIC INST OF CHINESE MEDICINE
优先权: 2011
CN
药物
反馈